FY 1991 budget resolution containing $624 mil. for FDA passed by the House of Representatives May 1. The allotment, which is set at the level needed to maintain current services with an update for inflation, does not assume any revenues from user fees. The Senate Budget Committee approved its budget resolution May 2, but did not include a specific FDA figure nor a position on user fees. Thus, those issues would be decided by Appropriations and Labor & Human Resources Committees. Resolution provides a general framework for spending by other congressional panels.
You may also be interested in...
Notified bodies’ efforts to enhance a harmonized approach to remote audits have failed, raising questions about whether there is any avenue left to get vital devices certified by the 26 May EU MDR deadline.
As Amneal’s generics segment sees significant growth, the company has revealed plans to launch new products and expand in new markets. “We are extremely proud of the progress our company has made since we re-joined as leaders of Amneal,” said Chirag and Chintu Patel, co-CEOs of Amneal.
Schemes and funding to support growth in the life sciences and medtech sectors featured in the UK government’s spring budget on 3 March.